Magnesium in PDB 5uoy: Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)

Enzymatic activity of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)

All present enzymatic activity of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One):
3.1.4.17;

Protein crystallography data

The structure of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One), PDB code: 5uoy was solved by E.P.Cedervall, C.K.Allerston, R.Xu, V.Sridhar, R.Barker, K.Aertgeerts, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 61.88 / 1.82
Space group P 43 21 2
Cell size a, b, c (Å), α, β, γ (°) 87.507, 87.507, 134.714, 90.00, 90.00, 90.00
R / Rfree (%) 18.9 / 22.1

Other elements in 5uoy:

The structure of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One) also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One) (pdb code 5uoy). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One), PDB code: 5uoy:

Magnesium binding site 1 out of 1 in 5uoy

Go back to Magnesium Binding Sites List in 5uoy
Magnesium binding site 1 out of 1 in the Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of Human PDE1B Catalytic Domain in Complex with Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl) Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2, 4]Triazolo[1,5-C]Pyrimidin-5(6H)-One) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg602

b:23.6
occ:1.00
O A:HOH712 1.9 22.9 1.0
O A:HOH803 2.0 21.4 1.0
OD1 A:ASP264 2.1 22.2 1.0
O A:HOH740 2.2 21.8 1.0
O A:HOH746 2.2 22.2 1.0
O A:HOH743 2.2 22.5 1.0
CG A:ASP264 3.1 21.8 1.0
OD2 A:ASP264 3.4 23.9 1.0
ZN A:ZN601 3.7 29.6 1.0
O A:HOH755 4.1 26.9 1.0
CD2 A:HIS263 4.1 23.5 1.0
NE2 A:HIS296 4.1 21.8 1.0
OE2 A:GLU293 4.2 24.4 1.0
O A:HIS263 4.2 22.5 1.0
OG1 A:THR334 4.3 22.9 1.0
CD2 A:HIS267 4.3 22.2 1.0
O A:HOH701 4.4 37.1 1.0
OD2 A:ASP370 4.4 33.6 1.0
CB A:ASP264 4.4 20.0 1.0
CD2 A:HIS296 4.5 20.7 1.0
NE2 A:HIS263 4.5 20.9 1.0
O A:HOH788 4.5 39.9 1.0
NE2 A:HIS267 4.6 23.6 1.0
NE2 A:HIS223 4.7 24.8 1.0
CA A:ASP264 4.8 20.4 1.0
O A:HOH824 4.8 54.8 1.0
O A:THR334 4.8 28.6 1.0
CB A:THR334 4.8 24.0 1.0
CD2 A:HIS223 4.8 20.8 1.0
CG A:GLU293 4.8 21.9 1.0
CD A:GLU293 4.9 28.9 1.0

Reference:

B.Dyck, B.Branstetter, T.Gharbaoui, A.R.Hudson, J.G.Breitenbucher, L.Gomez, I.Botrous, T.Marrone, R.Barido, C.K.Allerston, E.P.Cedervall, R.Xu, V.Sridhar, R.Barker, K.Aertgeerts, K.Schmelzer, D.Neul, D.Lee, M.E.Massari, C.B.Andersen, K.Sebring, X.Zhou, R.Petroski, J.Limberis, M.Augustin, L.E.Chun, T.E.Edwards, M.Peters, A.Tabatabaei. Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties. J. Med. Chem. V. 60 3472 2017.
ISSN: ISSN 1520-4804
PubMed: 28406621
DOI: 10.1021/ACS.JMEDCHEM.7B00302
Page generated: Mon Dec 14 21:16:42 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy